152 related articles for article (PubMed ID: 7358506)
21. Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques.
Eaton JD; Perry MJ; Todryk SM; Mazucco RA; Kirby RS; Griffiths JR; Dalgleish AG
Gene Ther; 2001 Apr; 8(7):557-67. PubMed ID: 11319623
[TBL] [Abstract][Full Text] [Related]
22. Occult carcinoma of the prostate: an oversight of immune surveillance--a working hypothesis.
Gittes RF; McCullough DL
J Urol; 1974 Aug; 112(2):241-4. PubMed ID: 4602934
[No Abstract] [Full Text] [Related]
23. [Autoimmunity of experimental animals with induced carcinoma. 1. Autotransplantability of rats with methylcholanthrene-induced sarcoma].
Takeda K; Aizawa M; Tsuji Y; Yamawaki S; Nakamura K
Saishin Igaku; 1965 Oct; 20(10):2826-35. PubMed ID: 5886833
[No Abstract] [Full Text] [Related]
24. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
25. Immunity in malignant disease.
Fairley GH
Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160
[No Abstract] [Full Text] [Related]
26. Methylcholanthrene-induced adenocarcinoma of the prostate in rats.
Cooper TP; Barham RE; Ansell JS
Surg Forum; 1974; 25(0):546-7. PubMed ID: 4439254
[No Abstract] [Full Text] [Related]
27. Evidence of determinant spreading in the antibody responses to prostate cell surface antigens in patients immunized with prostate-specific antigen.
Cavacini LA; Duval M; Eder JP; Posner MR
Clin Cancer Res; 2002 Feb; 8(2):368-73. PubMed ID: 11839651
[TBL] [Abstract][Full Text] [Related]
28. [Immune response against a human skin squamous cell carcinoma: humoral and cell-mediated immunity (author's transl)].
Kondo S; Aso K
Nihon Hifuka Gakkai Zasshi; 1980 Aug; 90(9):803-13. PubMed ID: 6968838
[No Abstract] [Full Text] [Related]
29. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
[TBL] [Abstract][Full Text] [Related]
30. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.
Zitzmann S; Mier W; Schad A; Kinscherf R; Askoxylakis V; Krämer S; Altmann A; Eisenhut M; Haberkorn U
Clin Cancer Res; 2005 Jan; 11(1):139-46. PubMed ID: 15671538
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a new rat model of head and neck squamous cell carcinoma.
Aubry K; Paraf F; Monteil J; Bessede JP; Rigaud M
In Vivo; 2008; 22(4):403-8. PubMed ID: 18712164
[TBL] [Abstract][Full Text] [Related]
32. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
Neeley YC; Arredouani MS; Hollenbeck B; Eng MH; Rubin MA; Sanda MG
Prostate; 2008 May; 68(7):715-27. PubMed ID: 18302222
[TBL] [Abstract][Full Text] [Related]
33. Toxicology and Carcinogenesis Studies of 4-Vinyl-1-cyclohexene Diepoxide (CAS No. 106-87-6) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Nov; 362():1-249. PubMed ID: 12695779
[TBL] [Abstract][Full Text] [Related]
34. Chemical induction of prostatic tumours in random-bred rats.
Gupta SK; Mathur IS; Kar AB
Indian J Exp Biol; 1971 Jul; 9(3):296-9. PubMed ID: 5144324
[No Abstract] [Full Text] [Related]
35. The Dunning R3327 prostate adenocarcinoma in the Fischer-Copenhagen F1 rat: a useful model for immunological studies.
Claflin AJ; McKinney EC; Fletcher MA
Oncology; 1977; 34(3):105-9. PubMed ID: 917439
[TBL] [Abstract][Full Text] [Related]
36. Rapid development of bronchiolo-alveolar squamous cell tumors in rats after intratracheal injection of 3-methylcholanthrene.
Schreiber H; Nettesheim P; Martin DH
J Natl Cancer Inst; 1972 Aug; 49(2):541-54. PubMed ID: 4342618
[No Abstract] [Full Text] [Related]
37. Cell surface antigens detectable by cytotoxic test on Friend virus-induced and Friend virus-infected tumors in the rat.
Shirai T; Kaji H; Takeichi N; Sendo F; Saito H
J Natl Cancer Inst; 1971 Mar; 46(3):449-60. PubMed ID: 5547310
[No Abstract] [Full Text] [Related]
38. Changes in the opsonin and cellular influences on phagocytosis during the growth of transplantable tumors.
Kampschmidt RF; Pulliam LA
J Reticuloendothel Soc; 1972 Jan; 11(1):1-10. PubMed ID: 5060134
[No Abstract] [Full Text] [Related]
39. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
Hwang C; Sanda MG
Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
[TBL] [Abstract][Full Text] [Related]
40. Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms.
Chen Z; Rosten SI; Lord EM; Gaspari AA
Reg Immunol; 1993; 5(5):285-92. PubMed ID: 8148238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
